-
Efficacy and Safety of Hepatic Artery Infusion Chemotherapy Combined with Donafenib and Camrelizumab in the Treatment of Patients with Unresectable Hepatocellular Carcinoma: A Retrospective, Single-Arm Study
09 Jul 2025 13:50 GMT
… multiple Phase III trials, attaining superior progression … in hepatobiliary surgery, medical oncology, infectious diseases, … chemotherapy perfusion: oxaliplatin (Sanofi (Hangzhou) Pharmaceutical Co., Ltd., … to the trial drug during the treatment period, short …
-
Drug Combo Outpaces Standard Chemo in R/R LBCL
09 Jul 2025 06:13 GMT
… months for the rituximab-gemcitabine-oxaliplatin (R-GemOx) regimen ( … (Lunsumio), which is FDA-approved for patients with … medicines, we hoped to build upon the success of these drugs … the SUNMO trial, noted that the current treatment landscape is …
-
Real-World Analysis Reveals Shorter Survival in KRAS G12C–Mutant Metastatic CRC After First-Line Treatment
07 Jul 2025 21:05 GMT
… demographics, clinicopathologic characteristics and treatment patterns, and survival outcomes … FOLFOX (fluorouracil, leucovorin, and oxaliplatin) with or without bevacizumab ( … Janssen, Merck, Pfizer, Revolution Medicine, Taiho, and Takeda; financial …
-
Bispecific Antibody Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
07 Jul 2025 17:00 GMT
… FDA-approved bispecific antibody list @ Bispecific Antibody Drugs … gemcitabine and oxaliplatin (GemOx) … Medicine
5.
Bispecific Antibody Clinical Trial … Bellicum Pharmaceuticals, Kecellitics Biotech Company, Yake Biotechnology, Minerva Biotechnologies, …
-
The CHALLENGE Trial Helps Redefine Adjuvant Therapy with Exercise in CRC
06 Jul 2025 23:12 GMT
… with oxaliplatin chemotherapy, a standard component of adjuvant treatment for … best medicine, and this was explored in the clinical trial. … normally get, things like oxaliplatin and chemotherapy, there … colon cancer: Canadian Cancer Trials Group (CCTG) CO.21 …
-
NICE relents on Takeda colorectal cancer drug Fruzaqla
03 Jul 2025 22:48 GMT
… mind and recommended the drug for use by the … to the treatment within the UK, as the Scottish Medicines Consortium … previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, … FRESCO and FRESCO-2 trials, which showed that it …
-
Asahi Kasei Pharma begins phase III study of promising CIPN prevention therapy, Recomodulin to enhance treatment options worldwide
03 Jul 2025 08:48 GMT
… Pharma has started trial drug administration in a … with Japan’s Pharmaceuticals and Medical Devices Agency (PDMA … chemotherapy including the platinum drug oxaliplatin.
“Patients undergoing … Pharma Corporation. “Limited treatment options for CIPN have …
-
Biomarker-Directed Therapies Improve Outlooks for the mCRC Treatment Arsenal: With Chandler Park, MD; and Midhun Malla, MD
03 Jul 2025 03:01 GMT
… Park, MD, a medical oncologist at Norton Cancer … areas, in accessing clinical trials, which remain a preferred … folinic acid, fluorouracil, and oxaliplatin) and second-line FOLFIRI ( … emphasized the importance of treatment sequencing, toxicity management, …
-
Asahi Kasei Pharma Starts Phase III Study of Promising CIPN Prevention Therapy, ART-123 (Recomodulin™), to Enhance Treatment Options Worldwide
02 Jul 2025 12:36 GMT
… Pharma has started trial drug administration in a … with Japan’s Pharmaceuticals and Medical Devices Agency (PDMA … chemotherapy including the platinum drug oxaliplatin.
“Patients undergoing … Pharma Corporation. “Limited treatment options for CIPN have …
-
Genetic Effects of Chemotherapy Revealed to Guide Cancer Treatment
01 Jul 2025 15:10 GMT
… a single or combination of drugs. The treatment can have long-term … , whereas other drugs in the same class, such as oxaliplatin, did not … patients continue with the treatment recommended by their doctor,” said David Scott …